|
|
||||||||
1Divisions of Nephrology and 2Epidemiology and Preventive Medicine, University of New Mexico Health Sciences Center, Albuquerque; 3Albuquerque Academy, Albuquerque, New Mexico; 4Department of Physiology, Louisiana State University Health Sciences Center, Shreveport, Louisiana; and 5Department of Surgery, University of Texas Medical Branch, Galveston, Texas
Submitted 7 June 2004 ; accepted in final form 12 July 2004
Alanine and glutamine constitute the two most important nitrogen carriers released from the muscle. We studied the intracellular amino acid transport kinetics and protein turnover in nine end-stage renal disease (ESRD) patients and eight controls by use of stable isotopes of phenylalanine, alanine, and glutamine. The amino acid transport kinetics and protein turnover were calculated with a three-pool model from the amino acid concentrations and enrichment in the artery, vein, and muscle compartments. Muscle protein breakdown was more than synthesis (nmol·min1·100 ml leg1) during hemodialysis (HD) (169.8 ± 20.0 vs. 125.9 ± 21.8, P < 0.05) and in controls (126.9 ± 6.9 vs. 98.4 ± 7.5, P < 0.05), but synthesis and catabolism were comparable pre-HD (100.7 ± 15.7 vs. 103.4 ± 14.8). Whole body protein catabolism decreased by 15% during HD. The intracellular appearance of alanine (399.0 ± 47.1 vs. 243.0 ± 34.689) and glutamine (369.7 ± 40.6 vs. 235.6 ± 27.5) from muscle protein breakdown increased during dialysis (nmol·min1·100 ml leg1, P < 0.01). However, the de novo synthesis of alanine (3,468.9 ± 572.2 vs. 3,140.5 ± 467.7) and glutamine (1,751.4 ± 82.6 vs. 1,782.2 ± 86.4) did not change significantly intradialysis (nmol·min1·100 ml leg1). Branched-chain amino acid catabolism (191.8 ± 63.4 vs. 59.1 ± 42.9) and nonprotein glutamate disposal (347.0 ± 46.3 vs. 222.3 ± 43.6) increased intradialysis compared with pre-HD (nmol·min1·100 ml leg1, P < 0.01). The mRNA levels of glutamine synthase (1.45 ± 0.14 vs. 0.33 ± 0.08, P < 0.001) and branched-chain keto acid dehydrogenase-E2 (3.86 ± 0.48 vs. 2.14 ± 0.27, P < 0.05) in the muscle increased during HD. Thus intracellular concentrations of alanine and glutamine are maintained during HD by augmented release of the amino acids from muscle protein catabolism. Although muscle protein breakdown increased intradialysis, the whole body protein catabolism decreased, suggesting central utilization of amino acids released from skeletal muscle.
amino acids; protein catabolism; nitrogen carriers; hemodialysis
This article has been cited by other articles:
![]() |
G. C Ligthart-Melis, M. C. van de Poll, P. G Boelens, C. H. Dejong, N. E. Deutz, and P. A. van Leeuwen Glutamine is an important precursor for de novo synthesis of arginine in humans Am. J. Clinical Nutrition, May 1, 2008; 87(5): 1282 - 1289. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. G. van de Poll, G. C. Ligthart-Melis, P. G. Boelens, N. E. P. Deutz, P. A. M. van Leeuwen, and C. H. C. Dejong Intestinal and hepatic metabolism of glutamine and citrulline in humans J. Physiol., June 1, 2007; 581(2): 819 - 827. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. C. Raj, O. Adeniyi, E. A. Dominic, M. A. Boivin, S. McClelland, A. H. Tzamaloukas, N. Morgan, L. Gonzales, R. Wolfe, and A. Ferrando Amino acid repletion does not decrease muscle protein catabolism during hemodialysis Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1534 - E1542. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. M. Cano, D. Fouque, and X. M. Leverve Application of Branched-Chain Amino Acids in Human Pathological States: Renal Failure J. Nutr., January 1, 2006; 136(1): 299S - 307S. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |